Health Technology Assessment (HTA) plays a critical role in evaluating the value of medical interventions. With the increasing availability of Electronic Health Records (EHRs), the integration of real-world data (RWD) […] The post The Importance of the ISPOR SUITABILITY Checklist in HTA Involving EHR Data appeared first on Marksman Healthcare ..read more

The role of patients and caregivers in health preference research (HPR) and patient-reported outcomes (PROs) research is critical for fostering patient-centered care. HPR involves recognizing and integrating the preferences of […] The post The Role of Patients and Caregivers in Health Preference and Patient-Reported Outcomes Research appeared first on Marksman Healthcare ..read more

Ensuring equitable access to life-saving medications in the pharmaceutical industry is a significant challenge. Tiered pricing, a strategy that adjusts drug prices based on the economic status of different markets, […] The post Tiered Pricing for Varied Markets: Is It of Value to Patient Access? appeared first on Marksman Healthcare ..read more

Assessing the value of interventions in rare diseases poses unique challenges due to the small patient populations and the heterogeneity of these conditions. Traditional statistical methods often fall short of […] The post The Win Ratio Method to Assess the Value of Interventions in Rare Diseases appeared first on Marksman Healthcare ..read more

Successfully bringing a pharmaceutical product from development to market adoption requires careful planning to establish its value. The rise of emerging markets and personalized medicine has transformed the pharmaceutical landscape, […] The post Maximizing Pharmaceutical Adoption: The Role of Early Value Definition Across Stakeholders appeared first on Marksman Healthcare ..read more

Systematic Literature Reviews (SLRs) are the gold standard in evidence synthesis, occupying the pinnacle of the evidence pyramid.[1] Their trustworthiness is paramount, as SLRs frequently form the foundation of evidence-based […] The post Assessing the Reliability of Published Systematic Literature Reviews appeared first on Marksman Healthcare ..read more

Health Economics and Outcomes Research (HEOR) is a critical component in the development and commercialization of new healthcare products. It provides essential insights that can shape clinical development strategies, inform […] The post When is the Ideal Moment to Start HEOR Activities Within Product Development? appeared first on Marksman Healthcare ..read more

Digital health technologies are revolutionizing the healthcare landscape through innovations such as wearable devices, telehealth platforms, AI-driven diagnostics, and digital therapeutics. Digital health technologies have the potential to enhance patient […] The post Market Access for Digital Health Assets: Creating Frameworks for Digital Health Technologies appeared first on Marksman Healthcare ..read more

In the dynamic landscape of pharmaceuticals, the role of medical affairs has evolved significantly over the years. The involvement of medical affairs is crucial at every stage of a pharmaceutical […] The post The Value of Medical Affairs in Every Phase of a Pharmaceutical Product Life Cycle appeared first on Marksman Healthcare ..read more

In the rapidly evolving landscape of healthcare, the role of medical affairs has become increasingly pivotal. As pharmaceutical companies navigate through the complexities of drug development and market access, integrating […] The post Integrating Value Planning into the Development of Medical Affairs: When and How? appeared first on Marksman Healthcare ..read more